MYR vs Preformed Line Products
MYRG and PLPC side by side, both in heavy construction other than building construction contractors. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MYRG and PLPC compare
MYR is the larger company, worth 3.0 times as much as Preformed Line Products ($4.4B against $1.5B).
On earnings, MYR is cheaper: it trades at 22.8× trailing earnings, against 25.3× for Preformed Line Products.
MYR grew revenue faster over the last twelve months (22.8% versus 16.3% for Preformed Line Products).
Preformed Line Products keeps more of each dollar of sales as profit, with a net margin of 7.6% compared with 4.5% at MYR.
Preformed Line Products pays a dividend yielding 0.28%; MYR does not pay one.
Preformed Line Products scores higher on the StockData Score (18 against 15 for MYR), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MYRG | PLPC |
|---|---|---|
| Size and price | ||
| Market cap | $4.4B | $1.5B |
| Share price | $280.67 | $301.00 |
| Change, 1 year | 20.9% | 40.5% |
| Change, 5 years | 140% | 348% |
| Beta (5Y) | 1.17 | 0.81 |
| Employees | 9,000 | 3,734 |
| StockData Score | ||
| Total score | 15 | 18 (better) |
| Valuation score | 4 (better) | 2 |
| Growth score | 4 (better) | 2 |
| Performance score | 3 | 4 (better) |
| Health score | 4 | 6 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 22.8× (better) | 25.3× |
| P/S | 1.0× (better) | 1.9× |
| P/B | – | 2.9× |
| EV/EBITDA | 13.3× (better) | 13.8× |
| P/FCF | 31.9× (better) | 40.5× |
| PEG | 1.49 | – |
| FCF yield | 3.1% (better) | 2.5% |
| Fair value | $340.01 | $227.89 |
| Margin of safety | 17.5% (better) | −32.1% |
| Growth | ||
| Revenue growth (TTM) | 22.8% (better) | 16.3% |
| Revenue growth, 5Y average | 10.2% (better) | 7.5% |
| Net income growth (TTM) | 97.5% (better) | 56.8% |
| EPS growth (TTM) | 98.9% (better) | 57.7% |
| EPS growth, 5Y average | 16.7% (better) | 3.6% |
| Profitability | ||
| Gross margin | 13.0% | 32.4% (better) |
| Operating margin | 6.1% | 10.1% (better) |
| Net margin | 4.5% | 7.6% (better) |
| FCF margin | 3.2% | 4.7% (better) |
| Return on equity | – | 12.0% |
| Return on invested capital | – | 12.7% |
| Financial health | ||
| Debt / equity | – | 0.10 |
| Net debt / EBITDA | 0.56 (better) | −0.44 |
| Interest coverage | 45.3× | 52.3× (better) |
| Current ratio | 1.33 | 2.85 (better) |
| Altman Z-score | 5.10 | 6.86 (better) |
| Piotroski F-score | 8 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.28% |
| Payout ratio | – | 7.1% |
| Years of dividend growth | – | 1 |
| Buyback yield | 0.03% (better) | −0.02% |
| Shareholder yield | 0.03% | 0.26% (better) |
| Ownership | ||
| Held by institutions | 99.7% | 70.0% |
| Held by insiders | 4.4% | 29.2% |
| Insider net buying, 12 months | −$10.5M | −$3.0M (better) |
| Short interest, % of float | 4.6% | 4.3% |
Go deeper
- MYRG stock overview
- MYRG income statement
- MYRG valuation and score
- PLPC stock overview
- PLPC income statement
- PLPC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.